Helicobacter pylori y el cáncer (2024)

Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annual Review of Pathology 2006; 1:63–96.

Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews 2006; 19(3):449–490.

Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: Evidence for sustained race/ethnic disparities. American Journal of Epidemiology 2012; 175(1):54–59.

Duan M, Li Y, Liu J, et al. Transmission routes and patterns of helicobacter pylori. Helicobacter 2023; 28(1):e12945.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon (FR): International Agency for Research on Cancer; 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 61. P. 1–241.

Zhou BG, Mei YZ, Wang JS, et al. Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies. Therapeutic Advances in Chronic Disease 2023; 14:20406223231155119.

Butt J, Epplein M. Helicobacter pylori and colorectal cancer—A bacterium going abroad? PLoS Pathogens 2019; 15(8):e1007861. doi: 10.1371/journal.ppat.1007861.

Zuo Y, Jing Z, Bie M, et al. Association between Helicobacter pylori infection and the risk of colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2020; 99(37):e21832.

Boustany A, Onwuzo S, Almomani A, Asaad I. Epidemiology and risk of colorectal cancer in patients with a history of Helicobacter pylori infection: A population-based study. Annals of Gastroenterology 2023; 36(2):203–207.

Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case–control studies nested within prospective cohorts. Gut 2001; 49(3):347–353.

Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. New England Journal of Medicine 1991; 325(16):1127–1131.

Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114(6):1169–1179.

Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis. American Journal of Gastroenterology 1999; 94(9):2373–2379.

Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. New England Journal of Medicine 2001; 345(11):784–789.

Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. Journal of the National Cancer Institute 2006; 98(20):1445–1452.

Yao P, Kartsonaki C, Butt J, et al. Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: A case–cohort study and meta-analysis. International Journal of Epidemiology 2023:dyad007.

Morais S, Costa A, Albuquerque G, et al. "True" Helicobacter pylori infection and non-cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project. Helicobacter 2022; 27(3):e12883.

Yang L, Kartsonaki C, Yao P, et al. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: A case–cohort study. The Lancet. Public Health 2021; 6(12):e888–e896.

Han Z, Liu J, Zhang W, et al. Cardia and non-cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta-analysis, and estimation of population attributable fraction. Helicobacter 2023 Jan 16:e12950.

Li WQ, Zhang JY, Ma JL, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: Follow-up of a randomized intervention trial. BMJ 2019; 366:l5016.

Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and Helicobacter pylori treatment. New England Journal of Medicine 2020; 382(5):427–436.

Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: A systematic review and meta-analysis. Gastroenterology 2016; 150(5):1113–1124.e5.

Parsonnet, J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. New England Journal of Medicine 1994; 330(18):1267–1271.

de Sanjose S, Dickie A, Alvaro T, et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiology, Biomarkers & Prevention 2004; 13(6):944–948.

Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: Experience from a large prospective series. Gut 2004; 53(1):34–37.

Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Annals of Oncology 2009; 20(6):1086–1093.

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians 2023; 73(1):17–48.

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2021; 71(3):209–249.

World Cancer Research Fund International. Stomach cancer statistics. Accessed February 28, 2023. (https://www.wcrf.org/cancer-trends/stomach-cancer-statistics/)

Rawla P, Barsouk A. Epidemiology of gastric cancer: Global trends, risk factors and prevention. Przegla̜d gastroenterologiczny (Gastroenterology review) 2019; 14(1):26–38.

Morgan E, Arnold M, Camargo MC, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study. EClinicalMedicine 2022; 47:101404.

Anderson WF, Rabkin CS, Turner N, et al. The changing face of noncardia gastric cancer incidence among US non-Hispanic Whites. Journal of the National Cancer Institute 2018; 110(6):608–615.

de Martel C, Forman D, Plummer M. Gastric cancer: Epidemiology and risk factors. Gastroenterology Clinics of North America 2013; 42(2):219–240.

Wu XC, Andrews P, Chen VW, Groves FD. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: Anatomic site and histology differences. Cancer Epidemiology 2009; 33(5):337–346.

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis. The Lancet. Global Health 2020; 8(2):e180–e190.

Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: A meta-analysis. Cancer Prevention Research 2008; 1(5):329–338.

Xie FJ, Zhang YP, Zheng QQ, et al. Helicobacter pylori infection and esophageal cancer risk: An updated meta-analysis. World Journal of Gastroenterology 2013; 19(36):6098–6107.

Nie S, Chen T, Yang X, Huai P, Lu M. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: A meta-analysis. Diseases of the Esophagus 2014; 27(7):645–653.

Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: Risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. Journal of the National Cancer Institute 2004; 96(5):388–396.

Whiteman DC, Parmar P, Fahey P, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010; 139(1):73–83; quiz e11-2.

Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Reviews in Molecular Medicine 2017; 19:e4.

Tu S, Bhagat G, Cui G, et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008; 14(5):408–419.

Murata-Kamiya N. Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. Microbes and Infection 2011; 13(10):799–807.

Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125(6):1636–1644.

Butt J, Varga MG, Wang T, et al. Smoking, Helicobacter pylori serology, and gastric cancer risk in prospective studies from China, Japan, and Korea. Cancer Prevention Research 2019; 12(10):667–674.

Gaddy JA, Radin JN, Loh JT, et al. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infection and Immunity 2013;81(6):2258–2267.

Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: Epidemiological and biological evidence. World Journal of Gastroenterology 2009; 15(18):2204–2213.

Ford AC, Yuan Y, Forman D, Hunt R, Moayyedi P. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database of Systematic Reviews 2020; 7(7):CD005583.

Chiang TH, Chang WJ, Chen SL, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands. Gut 2021; 70(2):243–250.

Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. New England Journal of Medicine 2018; 378(12):1085–1095.

Doorakkers E, Lagergren J, Santoni G, Engstrand L, Brusselaers N. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma. Helicobacter 2020; 25(3):e12688.

Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: Treatment of Helicobacter pylori infection. American Journal of Gastroenterology 2017; 112(2):212–239.

Katelaris P, Hunt R, Bazzoli F, et al. Helicobacter pylori World Gastroenterology Organization global guideline. Journal of Clinical Gastroenterology 2023; 57(2):111–126.

Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut 2022: gutjnl-2022-327745.

Herrero R, Park JY, Forman D. The fight against gastric cancer - the IARC Working Group report. Best Practice and Research. Clinical Gastroenterology 2014; 28(6):1107–1114.

Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF. Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: A systematic review and meta-analysis. American Journal of Gastroenterology 2022; 117(8):1221–1230.